|

Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.

RECRUITINGSponsored by University Hospital, Brest
Actively Recruiting
SponsorUniversity Hospital, Brest
Started2026-04-13
Est. completion2029-06-13
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07417605

Summary

This multicenter prospective observational study will evaluate the value of dynamic FDG-PET LAFOV imaging during the initial therapeutic assessment of a head and neck cancer 3 months after completion of curative radiotherapy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patient ≥ 18 years of age
* Presenting with head and neck squamous cell carcinoma
* Completed curative treatment with external radiation therapy
* Eligible for dynamic LAFOV FDG-PET scan for therapeutic evaluation at 3 months
* Having given consent for the end-of-treatment consultation

Exclusion Criteria:

* Hypersensitivity to 18F-FDG or other excipients contained in the contrast agent
* Pregnancy or breastfeeding
* History of treated upper gastrointestinal tract cancer
* Other histology
* Incomplete RTE treatment regimen
* Refusal to participate

Conditions2

CancerHead & Neck Squamous Cell Carcinoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.